HUP9700410A2 - Neuropeptid Y receptor antagonistát tartalmazó kozmetikai készítmény - Google Patents
Neuropeptid Y receptor antagonistát tartalmazó kozmetikai készítményInfo
- Publication number
- HUP9700410A2 HUP9700410A2 HU9700410A HUP9700410A HUP9700410A2 HU P9700410 A2 HUP9700410 A2 HU P9700410A2 HU 9700410 A HU9700410 A HU 9700410A HU P9700410 A HUP9700410 A HU P9700410A HU P9700410 A2 HUP9700410 A2 HU P9700410A2
- Authority
- HU
- Hungary
- Prior art keywords
- antagonist
- neuropeptide
- composition containing
- cosmetic composition
- receptor antagonist
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 4
- 239000002660 neuropeptide Y receptor antagonist Substances 0.000 title abstract 2
- 229940119154 Neuropeptide Y receptor antagonist Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 5
- 239000005557 antagonist Substances 0.000 abstract 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 3
- 239000011707 mineral Substances 0.000 abstract 3
- 241000194108 Bacillus licheniformis Species 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 230000004132 lipogenesis Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
- C09K2323/06—Substrate layer characterised by chemical composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Abstract
A találmány kőzmetikai készítményekre vőnatkőzik, amelyek legalább egyNPY-antagőnista kőmpőnenst tartalmaznak kőzmetikai készítményeknélfelhasználható vivőanyagőkkal és adőtt esetben egy a2-antagőnistakőmpőnenssel együtt.A találmány szerinti kőzmetikai készítményekben felhasználásra kerülőNPY-antagőnisták különösen előnyösen a, szintén a találmány tárgyátképző új, Streptőmyces sp SEBR 2794 törzs fermentációjával nyerik. Akészítményekben felhasználható a2-antagőnistát előnyösen a szintén atalálmány őltalmi körébe tartőzó új, Bacillűs lichenifőr-mis SEBR 2464törzs fermentációjával nyerik.A találmány szerinti kőzmetikai készítmények felhasználhatók a bőrön alipőlízis/lipőgenézis szabályőzására.ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612916A FR2754709B1 (fr) | 1996-10-23 | 1996-10-23 | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
Publications (4)
Publication Number | Publication Date |
---|---|
HU9700410D0 HU9700410D0 (en) | 1997-03-28 |
HUP9700410A2 true HUP9700410A2 (hu) | 1998-07-28 |
HUP9700410A3 HUP9700410A3 (en) | 1999-07-28 |
HU222663B1 HU222663B1 (hu) | 2003-09-29 |
Family
ID=9496938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9700410A HU222663B1 (hu) | 1996-10-23 | 1997-02-10 | Neuropeptid Y receptor antagonista és alfa2 antagonista kombinációját tartalmazó kozmetikai fogyasztó készítmény |
Country Status (23)
Country | Link |
---|---|
US (3) | US5827853A (hu) |
EP (3) | EP0838217B1 (hu) |
JP (1) | JP3411463B2 (hu) |
KR (1) | KR100240143B1 (hu) |
CN (1) | CN1214780C (hu) |
AR (1) | AR005583A1 (hu) |
AT (3) | ATE230974T1 (hu) |
AU (1) | AU705046B2 (hu) |
BR (1) | BR9700835A (hu) |
CA (1) | CA2196096C (hu) |
CO (1) | CO4780017A1 (hu) |
DE (3) | DE69739002D1 (hu) |
ES (3) | ES2313914T3 (hu) |
FR (1) | FR2754709B1 (hu) |
HK (1) | HK1008981A1 (hu) |
HU (1) | HU222663B1 (hu) |
IL (1) | IL120092A (hu) |
MX (1) | MX9700822A (hu) |
MY (1) | MY117993A (hu) |
PE (1) | PE799A1 (hu) |
PT (2) | PT1093803E (hu) |
SI (3) | SI0838217T1 (hu) |
TW (1) | TW434024B (hu) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728793A1 (fr) * | 1994-12-28 | 1996-07-05 | Oreal | Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US8466109B2 (en) * | 1998-10-05 | 2013-06-18 | Laboratoires Expanscience | Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
FR2787712B1 (fr) * | 1998-12-24 | 2002-08-30 | Sanofi Sa | Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique |
US6375948B1 (en) | 1999-07-12 | 2002-04-23 | Kao Corporation | Treating method for suppressing hair growth |
FR2800610B1 (fr) * | 1999-11-05 | 2001-12-28 | Sanofi Synthelabo | Composition cosmetique amincissante contenant une substance inducteur de la production d'il-6 |
WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
EP1337257A4 (en) * | 2000-10-03 | 2004-04-07 | Univ California | USE OF NEUROPEPTIDE Y ANTAGONISTS IN THE TREATMENT OF ALCOHOLISM |
US7069026B2 (en) * | 2001-06-28 | 2006-06-27 | Nokia Corporation | Geographic area assisted system selection for mobile stations |
WO2003009854A1 (en) * | 2001-07-20 | 2003-02-06 | Lonza Ag | Lipid lowering composition comprising carnitine and phytosterol |
EP1542719A4 (en) | 2001-12-05 | 2006-06-21 | Baylor College Medicine | METHODS AND COMPOSITIONS FOR REGULATING OS FORMATION BY MODULATING THE SYMPATHETIC TONUS |
US20030166732A1 (en) * | 2002-02-27 | 2003-09-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
FR2853541B1 (fr) * | 2003-04-09 | 2008-07-04 | Oreal | Composition cosmetique stable contenant un glyceride d'acides gras, un alcool et un emulsionnant silicone particulier |
WO2004098591A2 (en) | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
DE10340417C5 (de) * | 2003-09-02 | 2011-05-05 | Sebapharma Gmbh & Co. Kg | Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion |
EP1680120A2 (en) | 2003-11-03 | 2006-07-19 | Probiodrug AG | Combinations useful for the treatment of neuronal disorders |
CN1918131B (zh) | 2004-02-05 | 2011-05-04 | 前体生物药物股份公司 | 谷氨酰胺酰基环化酶抑制剂 |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
ATE480301T1 (de) * | 2004-06-15 | 2010-09-15 | Boots Co Plc | Haarpflegezusammensetzungen und verfahren |
FR2871688B1 (fr) | 2004-06-16 | 2008-05-16 | Oreal | Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre |
EP1877076A4 (en) * | 2005-04-15 | 2012-02-01 | Regenertech Pty Ltd | USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES |
AU2006255097B2 (en) * | 2005-06-06 | 2012-02-09 | Georgetown University | Compositions and methods for lipo modeling |
JP4960960B2 (ja) * | 2005-06-24 | 2012-06-27 | マルコ ブランデスティーニ | 衝撃による硬度測定装置 |
FR2895239B1 (fr) * | 2005-12-22 | 2008-05-30 | Oreal | Utilisation d'un antagoniste du neuropeptide y pour le soin des levres endommagees ou sensibles |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
SI2091948T1 (sl) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novi inhibitorji glutaminil ciklaze |
EP1970051A1 (en) * | 2007-03-14 | 2008-09-17 | Merz Pharma GmbH & Co.KGaA | Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
GB0719542D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Use of cocoa extract |
GB0719545D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Novel use of cocoa extract |
GB0719544D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Cocoa extract and use thereof |
WO2008157635A2 (en) * | 2007-06-19 | 2008-12-24 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid composition, method, and preparation |
US20080318870A1 (en) * | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
JOP20180077A1 (ar) * | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
US20090263518A1 (en) | 2008-04-17 | 2009-10-22 | Barry Callebaut Ag | Composition and Uses Thereof |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US20100233301A1 (en) * | 2009-03-11 | 2010-09-16 | Jing Cheng | Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same |
AU2010294214B2 (en) | 2009-09-11 | 2015-05-07 | Vivoryon Therapeutics N.V. | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
FR2953716B1 (fr) | 2009-12-16 | 2015-03-27 | Oreal | Kit de formulation d'un produit cosmetique |
JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
WO2012021133A1 (en) | 2010-08-12 | 2012-02-16 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
FR2967573B1 (fr) | 2010-11-23 | 2012-11-09 | Rhodia Poliamida E Especialidades Ltda | Kit cosmetique et utilisation pour ameliorer l'aspect de la peau |
WO2012112940A1 (en) | 2011-02-18 | 2012-08-23 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
NZ620040A (en) | 2011-08-23 | 2016-06-24 | Kythera Biopharmaceuticals Inc | Formulations of deoxycholic acid and salts thereof |
RS53419B (en) | 2011-08-23 | 2014-12-31 | Kythera Biopharmaceuticals, Inc. | FORMULATIONS OF DEOXYCHOLINIC ACID AND ITS SALTS |
US10272121B2 (en) | 2011-10-25 | 2019-04-30 | Arch Personal Care Product, Lp | Composition containing an extract of a sequential or simultaneous fermentation |
JP6300641B2 (ja) * | 2014-05-30 | 2018-03-28 | ワミレスコスメティックス株式会社 | 皮膚バリア機能改善効果を有する放線菌培養物 |
CA3003746A1 (en) | 2015-11-04 | 2017-05-11 | Kythera Biopharmaceuticals, Inc. | Treatments of accumulated fat with deoxycholic acid and salts thereof |
JP6938860B2 (ja) * | 2016-06-13 | 2021-09-22 | 株式会社リコー | 形状支持用液体、及び立体造形物の製造方法 |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2979511A (en) | 1959-03-25 | 1961-04-11 | Olin Mathieson | Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process |
DE2603407A1 (de) | 1976-01-29 | 1977-08-04 | Wmf Wuerttemberg Metallwaren | Wasserkessel |
IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
US4337260A (en) | 1981-09-10 | 1982-06-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazopyridine-spiro-piperidine compounds |
JPS59192086A (ja) * | 1983-04-15 | 1984-10-31 | Mitsui Toatsu Chem Inc | バチルス・リケニホルミスmn001 |
GB2138023A (en) * | 1983-03-29 | 1984-10-17 | Mitsui Toatsu Chemicals | Bacillus licheniformis used in animal feeds |
DE3410033A1 (de) | 1984-03-19 | 1985-09-26 | Alfred Teves Gmbh, 6000 Frankfurt | Vorrichtung zur hydraulischen unterstuetzung der lenkkraft |
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
GB2167408B (en) | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
JPS61155317A (ja) * | 1984-12-28 | 1986-07-15 | Lion Corp | 口腔用組成物 |
DE3545986A1 (de) * | 1985-12-23 | 1987-06-25 | Franz Sauter | Elektronisch gesteuertes musikinstrument |
DE3790919T1 (de) * | 1987-02-24 | 1989-03-23 | Inst Mikrobiologii Virusologii | Arzneimittel zur prophylaxe und behandlung von gastrointerfinalen erkrankungen des landwirtschaftsviehs |
DE3811193A1 (de) | 1988-04-01 | 1989-10-19 | Boehringer Ingelheim Kg | Neue peptide, verfahren zu ihrer herstellung und diese peptide enthaltende pharmazeutische zusammensetzungen |
US5328899A (en) | 1988-07-15 | 1994-07-12 | The Salk Institute For Biological Studies | NPY peptide analogs |
EP0356399A3 (en) * | 1988-08-26 | 1991-03-20 | Sandoz Ag | Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them |
ZA896374B (en) | 1988-08-26 | 1990-05-30 | Merrell Dow Pharma | Neuropeptide y antagonists |
US5116605A (en) * | 1989-03-09 | 1992-05-26 | Alt John P | Composition and skin treatment method therewith for mitigating acne and male-pattern baldness |
DE59006842D1 (de) | 1990-03-30 | 1994-09-22 | Heumann Pharma Gmbh & Co | Verwendung von Guanidinderivaten zur Herstellung eines Arzneimittels mit NPY-antagonistischer Wirkung. |
SE9002278L (sv) | 1990-06-28 | 1991-12-29 | Perstorp Ab | Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel |
SE467340B (sv) * | 1990-07-04 | 1992-07-06 | Perstorp Ab | Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist |
FR2669537B1 (fr) * | 1990-11-28 | 1993-02-19 | Oreal | Composition amincissante a base d'alpha-2-bloqueurs. |
TW263508B (hu) | 1991-02-12 | 1995-11-21 | Pfizer | |
WO1993012139A1 (en) | 1991-12-19 | 1993-06-24 | Garvan Institute Of Medical Research | A novel molecule which inhibits neuropeptide tyrosine biological function |
GB9213215D0 (en) | 1992-06-20 | 1992-08-05 | Wellcome Found | Peptides |
DE4326465A1 (de) | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
FR2701480B1 (fr) | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
DE4311756A1 (de) | 1993-04-08 | 1994-10-13 | Thomae Gmbh Dr K | Modifizierte Peptide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
EP0707490A1 (en) * | 1993-06-18 | 1996-04-24 | University Of Cincinnati | Neuropeptide y antagonists and agonists |
JPH07258068A (ja) * | 1994-03-18 | 1995-10-09 | Kao Corp | 浴用剤組成物 |
JP3447809B2 (ja) * | 1994-07-12 | 2003-09-16 | 花王株式会社 | 浴用剤 |
EP0705807B1 (en) * | 1994-10-06 | 1999-09-01 | Susumu Hibino | Bacterial preparation for agricultural use |
US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
EP0716854A3 (en) | 1994-10-20 | 1996-08-28 | Lilly Co Eli | Compositions for inhibiting neuropeptide Y |
BR9509610A (pt) * | 1994-11-07 | 1997-10-28 | Pfizer | Ligandos específicos de neuropeptideo Y1 |
FR2728793A1 (fr) * | 1994-12-28 | 1996-07-05 | Oreal | Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US5621079A (en) * | 1995-02-03 | 1997-04-15 | Merck & Co., Inc. | Neuropeptide Y receptor |
US5536499A (en) * | 1995-02-24 | 1996-07-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for reducing or preventing signs of cellulite |
US5552411A (en) | 1995-05-26 | 1996-09-03 | Warner-Lambert Company | Sulfonylquinolines as central nervous system and cardiovascular agents |
US5554621A (en) | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
US5552148A (en) * | 1995-06-07 | 1996-09-03 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Petroleum jelly with inositol phosphates |
US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
FR2787712B1 (fr) * | 1998-12-24 | 2002-08-30 | Sanofi Sa | Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique |
FR2788434B1 (fr) * | 1999-01-15 | 2001-05-11 | Oreal | Utilisation d'au moins un extrait d'au moins une bacterie filamenteuse non photosynthetique en tant qu'agent amincissant |
-
1996
- 1996-10-23 FR FR9612916A patent/FR2754709B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-23 ES ES01100818T patent/ES2313914T3/es not_active Expired - Lifetime
- 1997-01-23 AT AT97400161T patent/ATE230974T1/de active
- 1997-01-23 PT PT01100818T patent/PT1093803E/pt unknown
- 1997-01-23 SI SI9730475T patent/SI0838217T1/xx unknown
- 1997-01-23 AT AT01100818T patent/ATE408396T1/de active
- 1997-01-23 DE DE69739002T patent/DE69739002D1/de not_active Expired - Lifetime
- 1997-01-23 AT AT01100820T patent/ATE412399T1/de active
- 1997-01-23 ES ES01100820T patent/ES2316403T3/es not_active Expired - Lifetime
- 1997-01-23 DE DE69718409T patent/DE69718409T2/de not_active Expired - Lifetime
- 1997-01-23 DE DE69739079T patent/DE69739079D1/de not_active Expired - Lifetime
- 1997-01-23 EP EP97400161A patent/EP0838217B1/fr not_active Expired - Lifetime
- 1997-01-23 PT PT01100820T patent/PT1132463E/pt unknown
- 1997-01-23 EP EP01100818A patent/EP1093803B1/fr not_active Expired - Lifetime
- 1997-01-23 ES ES97400161T patent/ES2191154T3/es not_active Expired - Lifetime
- 1997-01-23 SI SI9730783T patent/SI1093803T1/sl unknown
- 1997-01-23 SI SI9730784T patent/SI1132463T1/sl unknown
- 1997-01-23 EP EP01100820A patent/EP1132463B1/fr not_active Expired - Lifetime
- 1997-01-27 US US08/790,761 patent/US5827853A/en not_active Expired - Lifetime
- 1997-01-27 CA CA002196096A patent/CA2196096C/en not_active Expired - Fee Related
- 1997-01-28 IL IL12009297A patent/IL120092A/en not_active IP Right Cessation
- 1997-01-29 AR ARP970100344A patent/AR005583A1/es active IP Right Grant
- 1997-01-31 BR BR9700835A patent/BR9700835A/pt not_active Application Discontinuation
- 1997-01-31 MX MX9700822A patent/MX9700822A/es unknown
- 1997-02-04 MY MYPI97000411A patent/MY117993A/en unknown
- 1997-02-04 AU AU12515/97A patent/AU705046B2/en not_active Ceased
- 1997-02-10 HU HU9700410A patent/HU222663B1/hu not_active IP Right Cessation
- 1997-02-13 JP JP02895097A patent/JP3411463B2/ja not_active Expired - Fee Related
- 1997-03-14 CN CNB971030375A patent/CN1214780C/zh not_active Expired - Fee Related
- 1997-03-19 KR KR1019970009736A patent/KR100240143B1/ko not_active IP Right Cessation
- 1997-03-21 CO CO97015478A patent/CO4780017A1/es unknown
- 1997-10-06 TW TW086114594A patent/TW434024B/zh not_active IP Right Cessation
- 1997-10-23 PE PE1997000944A patent/PE799A1/es not_active Application Discontinuation
-
1998
- 1998-07-20 US US09/119,031 patent/US6114336A/en not_active Expired - Lifetime
- 1998-08-07 HK HK98109761A patent/HK1008981A1/xx not_active IP Right Cessation
-
2000
- 2000-02-09 US US09/500,540 patent/US6313128B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9700410A2 (hu) | Neuropeptid Y receptor antagonistát tartalmazó kozmetikai készítmény | |
FR2774588B1 (fr) | Composition cosmetique ou dermatologique contenant au moins une proteine de soie d'arachnides naturelle, recombinante ou un analogue | |
ATE380539T1 (de) | Hautpflegezusammensetzungen, die silikonelastomere enthalten | |
AU3364001A (en) | Method for tabletting thickening systems | |
NO964966L (no) | Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav | |
AU7383798A (en) | Skin care compositions and method of improving skin appearance | |
AU7483398A (en) | Skin care compositions and method of improving skin appearance | |
DE59608385D1 (de) | Verwendung von mutierter subtilisin-protease in kosmetischen produkten | |
EP0875235A3 (en) | Hair cosmetics | |
DK0938570T3 (da) | Muteret alfa-amylase omfattende modifikation ved rester svarende til A210, H405 og/eller T412 i Bacillus licheniformis | |
FR2712286B1 (fr) | Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation. | |
DE3586697T2 (de) | Aktive thymopentin-analoga. | |
KR950700990A (ko) | 신규의 분비단백질 에프-스폰딘의 클로닝, 발현 및 용도 | |
DE69919950D1 (de) | Kosmetische zusammensetzung enthaltend einen polysacchariden von einem hydrothermalen bakterium | |
DE59707957D1 (de) | Verwendung von carboxylgruppenhaltigen Polysiloxanen in kosmetischen Formulierungen | |
HUP0000642A2 (hu) | Izzadásgátló vagy dezodoráló készítmény, valamint eljárás előállítására | |
CA2218078A1 (fr) | Composition cosmetique comprenant un polymere anionique acrylique et une silicone oxyalkylenee | |
ATE266375T1 (de) | Kosmetische zubereitungen | |
BR9915955A (pt) | Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona | |
IT1252061B (it) | Composizioni per uso dermatologico e cosmetico | |
DE59100496D1 (de) | Verwendung von selektiv hydrierten Styrol-Butadien-Copolymerisaten in kosmetischen und pharmazeutischen Zubereitungen. | |
IT1276459B1 (it) | Composizioni cosmetiche con proprieta' antimicotiche, efficaci contro la psoriasi e la caduta dei capelli e metodo cosmetico per la | |
DE59508843D1 (en) | 2-fluor-6-nitroaniline | |
EP0257189A3 (en) | Novel bacillus brevis strains and application thereof | |
FR2718640B1 (fr) | Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20030708 |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |